142 related articles for article (PubMed ID: 10091612)
1. Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease.
Mellick GD; Buchanan DD; McCann SJ; James KM; Johnson AG; Davis DR; Liyou N; Chan D; Le Couteur DG
Mov Disord; 1999 Mar; 14(2):219-24. PubMed ID: 10091612
[TBL] [Abstract][Full Text] [Related]
2. The monoamine oxidase B gene GT repeat polymorphism and Parkinson's disease in a Chinese population.
Mellick GD; Buchanan DD; Silburn PA; Chan DK; Le Couteur DG; Law LK; Woo J; Pang CP
J Neurol; 2000 Jan; 247(1):52-5. PubMed ID: 10701898
[TBL] [Abstract][Full Text] [Related]
3. Functional monoamine oxidase B gene intron 13 polymorphism predicts putaminal dopamine turnover in de novo Parkinson's disease.
Löhle M; Mangone G; Wolz M; Beuthien-Baumann B; Oehme L; van den Hoff J; Kotzerke J; Reichmann H; Corvol JC; Storch A
Mov Disord; 2018 Sep; 33(9):1496-1501. PubMed ID: 30216543
[TBL] [Abstract][Full Text] [Related]
4. The COMT L allele modifies the association between MAOB polymorphism and PD in Taiwanese.
Wu RM; Cheng CW; Chen KH; Lu SL; Shan DE; Ho YF; Chern HD
Neurology; 2001 Feb; 56(3):375-82. PubMed ID: 11171904
[TBL] [Abstract][Full Text] [Related]
5. MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD.
Hernán MA; Checkoway H; O'Brien R; Costa-Mallen P; De Vivo I; Colditz GA; Hunter DJ; Kelsey KT; Ascherio A
Neurology; 2002 May; 58(9):1381-7. PubMed ID: 12011284
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis on relationship of MAOB intron 13 polymorphisms, interactions with smoking/COMT H158L polymorphisms with the risk of PD.
Zhang Y; Piao X; Wu J; Li Y; Liang Q
Int J Neurosci; 2016; 126(5):400-7. PubMed ID: 26000819
[TBL] [Abstract][Full Text] [Related]
7. Association of monoamine oxidase B and catechol-O-methyltransferase polymorphisms with sporadic Parkinson's disease in an Iranian population.
Torkaman-Boutorabi A; Ali Shahidi G; Choopani S; Reza Zarrindast M
Folia Neuropathol; 2012; 50(4):382-9. PubMed ID: 23319194
[TBL] [Abstract][Full Text] [Related]
8. Catechol-O-methyltransferase and monoamine oxidase B genes and susceptibility to sporadic Parkinson's disease in a Polish population.
Białecka M; Droździk M; Honczarenko K; Gawrońska-Szklarz B; Stankiewicz J; Dabrowska E; Kubisiak M; Kłodowska-Duda G; Opala G
Eur Neurol; 2005; 53(2):68-73. PubMed ID: 15753616
[TBL] [Abstract][Full Text] [Related]
9. No association between Parkinson's disease and monoamine oxidase A and B gene polymorphisms.
Nanko S; Ueki A; Hattori M
Neurosci Lett; 1996 Feb; 204(1-2):125-7. PubMed ID: 8929994
[TBL] [Abstract][Full Text] [Related]
10. Detection and analysis of four polymorphic markers at the human monoamine oxidase (MAO) gene in Japanese controls and patients with Parkinson's disease.
Nakatome M; Tun Z; Shimada S; Honda K
Biochem Biophys Res Commun; 1998 Jun; 247(2):452-6. PubMed ID: 9642149
[TBL] [Abstract][Full Text] [Related]
11. The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease.
Białecka M; Droździk M; Kłodowska-Duda G; Honczarenko K; Gawrońska-Szklarz B; Opala G; Stankiewicz J
Acta Neurol Scand; 2004 Oct; 110(4):260-6. PubMed ID: 15355491
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence for association of a DRD2 allele.
Planté-Bordeneuve V; Taussig D; Thomas F; Said G; Wood NW; Marsden CD; Harding AE
Neurology; 1997 Jun; 48(6):1589-93. PubMed ID: 9191771
[TBL] [Abstract][Full Text] [Related]
13. Variability and validity of polymorphism association studies in Parkinson's disease.
Tan EK; Khajavi M; Thornby JI; Nagamitsu S; Jankovic J; Ashizawa T
Neurology; 2000 Aug; 55(4):533-8. PubMed ID: 10953187
[TBL] [Abstract][Full Text] [Related]
14. Association of a monoamine oxidase B allele with Parkinson's disease.
Kurth JH; Kurth MC; Poduslo SE; Schwankhaus JD
Ann Neurol; 1993 Apr; 33(4):368-72. PubMed ID: 8489207
[TBL] [Abstract][Full Text] [Related]
15. Impact of COMT H108L, MAOB int 13 A>G and DRD2 haplotype on the susceptibility to Parkinson's disease in South Indian subjects.
Kumudini N; Umai A; Devi YP; Naushad SM; Mridula R; Borgohain R; Kutala VK
Indian J Biochem Biophys; 2013 Oct; 50(5):436-41. PubMed ID: 24772965
[TBL] [Abstract][Full Text] [Related]
16. Association of monoamine oxidase A gene polymorphism with Alzheimer's disease and Lewy body variant.
Takehashi M; Tanaka S; Masliah E; Ueda K
Neurosci Lett; 2002 Jul; 327(2):79-82. PubMed ID: 12098640
[TBL] [Abstract][Full Text] [Related]
17. Family-based case-control study of MAOA and MAOB polymorphisms in Parkinson disease.
Kang SJ; Scott WK; Li YJ; Hauser MA; van der Walt JM; Fujiwara K; Mayhew GM; West SG; Vance JM; Martin ER
Mov Disord; 2006 Dec; 21(12):2175-80. PubMed ID: 17044053
[TBL] [Abstract][Full Text] [Related]
18. Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease.
Hotamisligil GS; Girmen AS; Fink JS; Tivol E; Shalish C; Trofatter J; Baenziger J; Diamond S; Markham C; Sullivan J
Mov Disord; 1994 May; 9(3):305-10. PubMed ID: 7913737
[TBL] [Abstract][Full Text] [Related]
19. [Polymorphism of MAO-B gene and NAD(P)H: quinone oxidoreductase gene in Parkinson's disease].
Shao M; Liu Z; Tao E; Chen B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):122-4. PubMed ID: 11295131
[TBL] [Abstract][Full Text] [Related]
20. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.
Tong J; Rathitharan G; Meyer JH; Furukawa Y; Ang LC; Boileau I; Guttman M; Hornykiewicz O; Kish SJ
Brain; 2017 Sep; 140(9):2460-2474. PubMed ID: 29050386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
